Status:
UNKNOWN
Managing Diabetes During Pregnancy in the Wireless Age
Lead Sponsor:
Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Collaborating Sponsors:
Ontario Ministry of Health and Long Term Care
Conditions:
Gestational Diabetes Mellitus
Type 2 Diabetes Mellitus
Eligibility:
FEMALE
18-50 years
Phase:
NA
Brief Summary
This Randomized Controlled Trial (RCT) will test the efficacy of a home blood glucose telemonitoring system against usual care in women with gestational diabetes mellitus (GDM) or type 2 diabetes mell...
Detailed Description
Establishing good glycemic control is crucial for the treatment of patients with gestational diabetes mellitus (GDM) and type 2 diabetes mellitus (DM2). High levels of blood glucose in pregnancy may l...
Eligibility Criteria
Inclusion
- patients must be pregnant
- diagnosed with gestational diabetes or Type 2 diabetes
- must be comfortable with instructions in English and be able to express themselves using simple phrases in English.
Exclusion
- unable to complete self monitoring of blood glucose (SMBG) for any reason
- uncomfortable with the use of the telemonitoring equipment
- develop an acute illness requiring hospitalization, where they may deviate from the normal delivery of care
- refusal to sign consent form or to carry out the demands made by the study
Key Trial Info
Start Date :
January 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2012
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01474525
Start Date
January 1 2010
End Date
March 1 2012
Last Update
November 21 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mount Sinai Hospital, Leadership Sinai Centre for Diabetes
Toronto, Ontario, Canada, M5T 3L9